• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > Viewpoints > Como acabar de vez com as doenças negligenciadas? > Page 2

Como acabar de vez com as doenças negligenciadas?

9 Apr 2025

By Sergio Sosa-Estani, Continental Lead Americas and Latin America Director, DNDi

Dengue, Chagas, leishmaniose… As doenças tropicais negligenciadas (DTNs) afetam, anualmente, mais de 1 milhão de pessoas e fazem mais de 200 mil vítimas fatais, de acordo com a Organização Mundial da Saúde (OMS).

Elas formam um grupo de 21 enfermidades determinadas pela OMS que prevalecem principalmente em áreas de extrema pobreza. As DTNs recebem esse nome porque são ignoradas sobretudo pela indústria farmacêutica privada.

Por atingirem populações vulneráveis, não representam um mercado lucrativo e, assim, não despertam interesse de investimentos em pesquisa e desenvolvimento de novos tratamentos.

O termo “negligenciadas” não se refere apenas às doenças, mas também às pessoas que convivem com elas. Enquanto lidam com dores crônicas e outros sintomas, muitas delas ainda enfrentam o estigma social.

Read the viewpoint published in Veja Saúde

Partnership Chagas disease Cutaneous leishmaniasis Dengue Latin America

Read, watch, share

Loading...
Stories
14 Apr 2025

DNDi supporting a pioneering project that integrates Indigenous knowledge in the treatment of Chagas

C&EN logo
Viewpoints
3 Apr 2025

Opinion: How patents can serve the common good

Chemical & Engineering News
TRT Afrika logo
Viewpoints
3 Apr 2025

Africa’s greatest health challenges won’t be solved without female scientists

TRT Afrika
News
3 Apr 2025

DNDi looking for a new Patient Representative to join its Board of Directors

Drug Discovery Explained: Episode 3 What is lead optimization?
Stories
26 Mar 2025

Drug discovery explained: What is lead optimization?

Lab activities
Press releases
18 Mar 2025

DNDi welcomes GHIT support for new collaboration with Shionogi to identify novel drug candidates for neglected Chagas disease

Nature India Logo
Viewpoints
8 Mar 2025

Women are poorly represented in clinical trials. That’s problematic

Nature India
Veja Saúde
Viewpoints
17 Feb 2025

Doença do sono derrotada: lições de uma bem-sucedida missão na África

Veja Saúde
VIEW ALL

Help neglected patients

To date, we have delivered thirteen new treatments, saving millions of lives.

Our goal is to deliver 25 new treatments in our first 25 years. You can help us get there. 

GIVE NOW
Linkedin-in Instagram Twitter Facebook-f Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License